IP Library › Granted Patent US 10,675,377
Granted Patent B2
US 10,675,377 · App. 15/803,450 · Granted Jun 9, 2020

Method for the production of a polymethylmethacrylate bone cement, bone cement kit for use in said method, and bone cement produced by said method

Inventors: Sebastian Vogt (Erfurt, DE); Thomas Kluge (Vallendar, DE)
Assignee: Heraeus Medical GmbH
A61L24/046A61L24/001A61L24/06A61L27/16A61L27/50C08F20/18C08K3/36C08K5/14C08L33/12A61L2430/02C08K2003/2241C08L2203/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,675,377
App. No.
15/803,450
Granted
Jun 9, 2020
Kind
B2
Abstract

A polymethylmethacrylate bone cement is produced by a method. The method comprises the steps of a) providing a cement powder comprising: at least one particulate polymethylmethacrylate or polymethylmethacrylate-copolymer wherein the at least one particulate polymethylmethacrylate or polymethylmethacrylate-copolymer have a particle size of less than 100 μm; an initiator; and at least one particulate or fibrous additive that is insoluble in methylmethacrylate, wherein the additive has an absorption capacity at room temperature of more than or equal to 0.6 g methylmethacrylate per gram of additive; b) providing a monomer solution comprising: at least one methylmethacrylate; and at least one activator; and c) mixing the cement powder and the monomer solution, characterised in that the mixing takes place without the application of shearing forces.

Claims (48)

1. A method for the production of a polymethylmethacrylate bone cement comprising the steps of:

a) providing a cement powder composition comprising:

at least one particulate polymethylmethacrylate or polymethylmethacrylate-copolymer, wherein the at least one particulate polymethylmethacrylate or polymethylmethacrylate-copolymer has a particle size of less than 100 μm;

an initiator comprising a peroxide compound; and

at least one particulate or fibrous additive that is insoluble in methylmethacrylate, wherein the at least one particulate or fibrous additive has an absorption capacity at room temperature of more than or equal to 0.6 g methylmethacrylate per gram of the at least one particulate or fibrous additive;

b) providing a monomer liquid comprising:

at least one methylmethacrylate monomer; and

at least one activator comprising an aromatic amine; and

c) mixing the cement powder composition and the monomer liquid, such that the monomer liquid contacts the cement powder composition to produce a homogenous dough without mechanical mixing, wherein the cement powder composition comprises intervening spaces, wherein the intervening spaces account for between 25% by volume and 40% of the cement powder composition.

2. The method of claim 1 , wherein the at least one particulate or fibrous additive comprises covalently bound hydroxyl groups on its surface.

3. The method of claim 1 , wherein the at least one particulate or fibrous additive is selected from the group consisting of microcrystalline cellulose, oxycellulose, titanium dioxide, and silicon dioxide.

4. The method of claim 1 , wherein the at least one particulate or fibrous additive is pyrogenic silicon dioxide.

5. The method of claim 1 , wherein the at least one particulate or fibrous additive has a particle size of less than 100 μm.

6. The method of claim 5 , wherein the at least one particulate or fibrous additive has a particle size of less than 50 μm.

7. The method of claim 6 , wherein the at least one particulate or fibrous additive has a particle size of less than 10 μm.

8. The method of claim 1 wherein the at least one particulate polymethylmethacrylate or polymethylmethacrylate-copolymer was passed through a 100 μm mesh sieve.

9. The method of claim 1 , wherein the cement powder contains the additive in an amount of 0.1 to 2.5% by weight, relative to the total weight of the cement powder.

10. A bone cement kit, wherein the kit comprises:

a) a cement powder composition comprising:

at least one particulate polymethylmethacrylate or polymethylmethacrylate-copolymer wherein the at least one particulate polymethylmethacrylate or polymethylmethacrylate-copolymer has a particle size of less than 100 μm;

an initiator comprising a peroxide compound; and

at least one particulate or fibrous additive that is insoluble in methylmethacrylate, wherein the at least one particulate or fibrous additive has an absorption capacity at room temperature of more than or equal to 0.6 g methylmethacrylate per gram of the at least one particulate or fibrous additive; and

b) a monomer liquid comprising:

at least one methylmethacrylate monomer; and

at least one activator comprising an aromatic amine, wherein the cement powder composition comprises intervening spaces, wherein the intervening spaces account for between 25% by volume and 40% of the cement powder composition.

11. The kit of claim 10 , wherein the at least one particulate or fibrous additive comprises covalently bound hydroxyl groups on its surface.

12. The kit of claim 10 , wherein the at least one particulate or fibrous additive is selected from the group consisting of microcrystalline cellulose, oxycellulose, titanium dioxide, and silicon dioxide.

13. The kit of claim 10 , wherein the at least one particulate or fibrous additive is pyrogenic silicon dioxide.

14. The kit of claim 10 , wherein the at least one particulate or fibrous additive has a particle size of less than 100 μm.

15. The kit of claim 14 , wherein the at least one particulate or fibrous additive has a particle size of less than 50 μm.

16. The kit of claim 15 , wherein the at least one particulate or fibrous additive has a particle size of less than 10 μm.

17. The kit of claim 10 , wherein the cement powder—composition comprises the additive in an amount of 0.1 to 2.5% by weight, relative to the total weight of the cement powder.

18. The kit of claim 10 , wherein the monomer liquid comprises methylmethacrylate.

19. The kit of claim 10 , wherein the polymer powder composition comprises dibenzoyl peroxide as the initiator.

20. The kit of claim 10 , wherein the monomer liquid further comprises at least one radical stabiliser selected from the group consisting of quinones and sterically hindered phenols.

21. The kit of claim 10 , wherein the cement powder composition further comprises a particulate radiopaque agent.

22. The kit of claim 21 , wherein the cement powder composition comprises:

0.4-3.0% by weight of dibenzoylperoxide as the initiator;

79.5-99.3% by weight of the polymethylmethacrylate and/or polymethylmethacrylate-copolymer; and

0.1-2.5% by weight of the at least one particulate or fibrous additive.

23. The kit of claim 10 , wherein the cement powder composition further comprises an anti-infective agent or antiseptic agent.

24. The kit of claim 23 wherein the cement powder composition comprises:

1.0-10% by weight of the anti-infective agent or antiseptic agent;

0.0-15.0% by weight of a radiopaque agent;

0.4-3.0% by weight of dibenzoylperoxide as the initiator;

69.5-98.3% by weight of the polymethylmethacrylate and/or polymethylmethacrylate-copolymer; and

0.1-2.5% by weight of the at least one particulate or fibrous additive.

25. The bone cement produced by claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2018
From: VOGT, SEBASTIAN; KLUGE, THOMAS
To: HERAEUS MEDICAL GMBH
Reel/Frame 044736/0280 →
Priority Claims (1)
DE 10 2016 222 158 · Nov 11, 2016 · national
Continuity (1)
Related Publication 20180133361A1 · May 17, 2018